Navigation Links
Rigel Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/1/2011

s of historical fact may be deemed to be forward-looking statements. Words such as "may," "intend," "believe," "expect," "potential," and similar expressions are intended to identify these forward-looking statements. These forward-looking statements are based upon Rigel's current expectations and involve risks and uncertainties. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including, without limitation, risks associated with Rigel's need for additional capital, the timing and success of preclinical studies and clinical trials and the potential problems that may arise in the research and development and approval process, as well as other risks detailed from time to time in Rigel's SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2010. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.Contact: Ryan D. Maynard
Phone: 650.624.1284
Email: invrel@rigel.comMedia Contact: Susan C. Rogers, Alchemy Consulting, Inc.
Phone: 650.430.3777
Email: susan@alchemyemail.comSTATEMENTS OF OPERATIONS(in thousands, except per share amounts)Three Months Ended December 31,Twelve Months Ended December 31,2010200920102009(unaudited)Revenues:Contract revenues

$
-

$
750$ 125,000

$
750Operating expenses:Research and development (see Note A)

13,758

20,17564,392

90,743General and administrative (see Note A)

5,911

5,67725,291

20,903Restructuring charges (see Note A)

-

--

1,141Total operating expenses

19,669

25,85289,683

112,787Income (loss) from operations

(19,66
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
(Date:7/31/2014)... -- Decision Resources Group is launching an extension of its ... include ChinaTrack; the new capabilities track the ... providing detailed brand-level share tracking and analytics. ChinaTrack also ... Other key capabilities of the new line extension: ... end-user surveys of healthcare facilities, ChinaTrack data is paired ...
(Date:7/31/2014)... July 31, 2014 For its innovative modular ... , Art,s-Way Scientific has earned a Modular Building ... competition in over 30 categories, MBI,s contest is the ... which include building manufacturers, dealers, and product and service ... example the capability of our team," said Dan ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
(Date:7/31/2014)... CO (PRWEB) July 31, 2014 LDM ... new eDiscovery pricing model that is simplified and predictable ... any size. As a leading international provider of ... government agencies it has become glaringly apparent that both ... unpredictable ballooning eDiscovery budgets and the complex pricing structure ...
(Date:7/31/2014)... News) -- With the World Health Organization reporting that ... has risen to 729, the U.S. Centers for ... warning for,the region. The "Level 3 travel advisory" ... -- Guinea, Liberia and Sierra Leone -- be avoided. ... in West Africa," CDC Director Dr. Tom Frieden told ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Setting goals for ... on blogs on successful tips to weight loss. Fitness on ... for over 8 years, and has worked with 6000 customers ... “We have had the chance to monitor why customers start ... exercising, how long they stick to their program, whether or ...
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular ... open a snorers airway to quiet snoring. , Dawn M. ... relationship with her husband by allowing them to share the same ... snoring began about 15 years ago and I remember nights when ... sleep and had to head downstairs for any relief. As the ...
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... grow, as Bernstein Liebhard LLP notes that Johnson ... it plans to voluntarily remove its power morcellators ... a report from Bloomberg.com, the company said it ... benefits associated with the devices remain uncertain.* , ...
Breaking Medicine News(10 mins):Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Fitness on the Go's Rewards Program Helps Clients Reach Their Goals 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3
... explore the relationship between the size of a brain structure ... been found out that the same region // of the ... the overall personality of the individual. , It ... an area of the brain called the medial orbitofrontal cortex ...
... that the weight gained during the holiday season is never ... ,The weight gain starts from the Thanksgiving weekend and ... of the holiday bulge., ,To stop this bulge a ... more fruits and non-fat yogurt, drink skimmed milk, drink in ...
... Christina Desforges a teenage girl died due to Peanut allergy ... , Desforges is from the city of Saguenay, though ... she could not be cured of the hypersensitivity reaction and ... the death is being investigated and an autopsy has been ...
... grants that were designed to nlure health practioners to distant ... failed for the dental segment in the Scottish area of ... grant per dentist to enable them to move to areas ... It has emerged not that only about five dentists have ...
... outbreak of H5N1 avian influenza has been confirmed in ... bird flu outbreak is the 23rd in China since ... died in Inner Mongolia's Zalantun city last Sunday, the ... 16,567 birds at poultry farms within three,km of the ...
... journal Nutrition and Cancer says that Zyflamend, an herbal extract from ... prostate cancer.// ,It was found that this element caused ... the drug had the ability to inhibit 78 percent of the ... natural process by which a cell dies. Cell death in this ...
Cached Medicine News:Health News:Fear Factor Found To Be Crucial In Shaping An Individual’s Personalit 2
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Girard angled tying forceps made of titanium has angled 45 shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 102 mm....
Angled tying forceps made of titanium has angled shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 102 mm....
Medicine Products: